Expertise in
4
conditions

Dr. Andrea M. Haqq

Pediatric Endocrinology
Office
2100 Erwin Rd, 
Durham, NC 
Accepting New Patients
Referral may be required
Before you request
Expertise in
4
conditions
Office
2100 Erwin Rd, 
Durham, NC 

Overview

Andrea Haqq is a Pediatric Endocrinologist practicing medicine in Durham, North Carolina.

Dr. Haqq is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Prader-Willi Syndrome, Obesity, Obesity in Children, Sleeve Gastrectomy, and Islet Cell Transplantation.

She is actively involved in clinical research, co-authoring 87 peer reviewed articles and participating in 7 clinical trials. Dr. Haqq is currently accepting new patients.

Specialties

Pediatric Endocrinology

Licenses

Internal Medicine in NC

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
2100 Erwin Rd, Durham, NC 27705

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2/Phase 3
A Phase 3 Trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
A Phase 3 Trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
Enrollment Status: Completed
Publish Date: December 01, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 3
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Enrollment Status: Completed
Publish Date: November 15, 2022
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Drug: Intranasal carbetocin
Study Phase: Phase 3
The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry Involving Variants in Hypothalamic Genes Upstream or Downstream From the Melanocortin-4 Receptor (MC4R)
The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry Involving Variants in Hypothalamic Genes Upstream or Downstream From the Melanocortin-4 Receptor (MC4R)
Enrollment Status: Completed
Publish Date: May 04, 2021
A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: March 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

87 Total Publications

Clinical, Genetic, and Endocrine Features of Bardet-Biedl Syndrome in a Pediatric and Adult Cohort.
Clinical, Genetic, and Endocrine Features of Bardet-Biedl Syndrome in a Pediatric and Adult Cohort.
Journal: American journal of medical genetics. Part A
Published: February 19, 2026
Similar Doctors
Expertise in
4
conditions
Dr. Michael S. Freemark
Pediatric Endocrinology
Expertise in
4
conditions
Dr. Michael S. Freemark
Pediatric Endocrinology
Referral may be required
Before you request

Private Diagnostic Clinic PLLC

2100 Erwin Rd, 
Durham, NC 
 (0.1 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Freemark is a Pediatric Endocrinologist practicing medicine in Durham, North Carolina. Dr. Freemark is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Prader-Willi Syndrome, Obesity, Obesity in Children, and Congenital Hyperinsulinism. Dr. Freemark is currently accepting new patients.

Expertise in
2
conditions
Dr. Jennifer R. Law
Pediatric Endocrinology
Expertise in
2
conditions
Dr. Jennifer R. Law
Pediatric Endocrinology
Referral may be required
Before you request

UNC Hospitals Pediatric Endocrinology

101 Manning Dr # 7039, 
Chapel Hill, NC 
 (7.1 miles away)
833-922-8800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jennifer Law is a Pediatric Endocrinologist practicing medicine in Chapel Hill, North Carolina. Dr. Law is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Turner Syndrome, Intersex, Mixed Gonadal Dysgenesis, and Mosaicism. Dr. Law is currently accepting new patients.

Expertise in
1
conditions
Dr. Robert W. Benjamin
Pediatric Endocrinology
Expertise in
1
conditions
Dr. Robert W. Benjamin
Pediatric Endocrinology
Referral may be required
Before you request

Office

4101 N Roxboro St, 
Durham, NC 
 (3.1 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Benjamin is a Pediatric Endocrinologist practicing medicine in Durham, North Carolina. Dr. Benjamin is highly rated in 1 condition, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Hypogonadism, and Hypogonadotropic Hypogonadism. Dr. Benjamin is currently accepting new patients.

Frequently Asked Questions about Dr. Andrea M. Haqq

How do I make an appointment with Dr. Andrea M. Haqq?

You can book an appointment with Dr. Andrea M. Haqq by calling their office at 919-620-4467. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrea M. Haqq a top-rated expert for Prader-Willi Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrea M. Haqq is classified as an Elite expert for Prader-Willi Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrea M. Haqq specialize in?

While Dr. Andrea M. Haqq is a Pediatric Endocrinology, they have specific expertise in Prader-Willi Syndrome, Obesity, and Obesity in Children. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Andrea M. Haqq participate in research or clinical trials?

Yes. Dr. Andrea M. Haqq has published 87 articles and abstracts on conditions like Prader-Willi Syndrome. You can view a list of Dr. Andrea M. Haqq's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Haqq's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile